Screener
Ligand Pharmaceuticals LGND Agenus Inc. — Financial Royalty Assets, Net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept lgnd:FinancialRoyaltyAssetsNet.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
| Line item | June 30, 2026 / Gross carrying value(1) | June 30, 2026 / Allowance | June 30, 2026 / Net carrying value (1) | December 31, 2025 / Gross carrying value(1) | December 31, 2025 / Allowance | December 31, 2025 / Net carrying value(1) |
|---|---|---|---|---|---|---|
| Qarziba | $101,303 | $(468) | $100,835 | $118,593 | $(498) | $118,095 |
| Agenus Bot/Bal | 40,815 | (408) | 40,407 | 40,815 | (408) | 40,407 |
| Tolerance Therapeutics (Tzield®) | 25,470 | (99) | 25,371 | 25,257 | (98) | 25,159 |
| Ohtuvayre inventors | 19,957 | (179) | 19,778 | 16,921 | (151) | 16,770 |
| Elutia (CorMatrix) | 6,062 | (837) | 5,225 | 6,607 | (1,107) | 5,500 |
| AT220 | 4,442 | (109) | 4,333 | 5,132 | (132) | 5,000 |
| Primrose mRNA | 3,281 | (98) | 3,183 | 3,281 | (98) | 3,183 |
| Zerion | 2,640 | (79) | 2,561 | — | — | — |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ligand Pharmaceuticals's agenus inc. — financial royalty assets, net?
- Ligand Pharmaceuticals (LGND) reported agenus inc. — financial royalty assets, net of $40.41M in Q2 2026.
- What does agenus inc. — financial royalty assets, net mean?
- This represents the current book value of royalty assets related to Agenus Inc. after accounting for all applicable allowances and valuation adjustments. It provides a net carrying amount that reflects the expected recoverable value of the future royalty streams from these specific drug assets. Investors use this figure to assess the tangible value remaining on the balance sheet from this specific partnership segment.
Ask your AI about Ligand Pharmaceuticals's agenus inc. — financial royalty assets, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude